Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 768899

Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome


Lucijanić, Marko; Pejša, Vlatko; Mitrović, Zdravko; Štoos-Veić, Tajana; Livun, Ana; Jakšić, Ozren; Vasilj, Tamara; Piršić, Mario; Hariš, Višnja; Prka, Željko; Kušec, Rajko
Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome // Hematology (Luxembourg), 21 (2015), 3; 170-174 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 768899 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome

Autori
Lucijanić, Marko ; Pejša, Vlatko ; Mitrović, Zdravko ; Štoos-Veić, Tajana ; Livun, Ana ; Jakšić, Ozren ; Vasilj, Tamara ; Piršić, Mario ; Hariš, Višnja ; Prka, Željko ; Kušec, Rajko

Izvornik
Hematology (Luxembourg) (1024-5332) 21 (2015), 3; 170-174

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Myelodysplastic syndrome; HFE; C282Y; H63D; Iron metabolism; Overall survival

Sažetak
The recent availability of potent oral iron chelators is renewing an interest in the assessment of the possible impact of HFE genetics in myelodysplastic syndrome (MDS). Thirty-six newly diagnosed patients with MDS were studied for parameters of iron metabolism in addition to C282Y and H63D mutations of the HFE gene. Mutations were present in 11 out of 36 patients (31%), which was not different from our general population and were equally distributed among MDS subtypes. Mutated patients had higher ferritin levels (P = 0.039) and lower TIBC (P = 0.018). Ferritin was found to be higher for the untransfused mutated patients (P = 0.017), but not for transfusion- dependent patients in whom ferritin levels correlated significantly with the number of blood units received (P = 0.04). There was no difference in the number of blood units received between the mutated and wild type patients. A new observation made was that the mutated patients had a lower overall survival in addition to a poorer leukemia free survival (P = 0.004 and P = 0.003, respectively). The HFE gene mutations are not more frequent in MDS patients. Iron overload in mutated patients was higher but there was no correlation found using supportive therapy for anemia. The effect of mutations on survival could be mediated by changes in iron metabolism. The HFE genotype may predict MDS prognosis and there is a need for further studies. It remains a challenging question if HFE mutated MDS patients should be considered for potent iron chelation therapy.

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
108-1980955-3094 - Genetika i funkcija hematopoeze i mikrookoliša Ph- mijeloproliferativnih bolesti (Kušec, Rajko, MZOS ) ( POIROT)

Ustanove:
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava"


Citiraj ovu publikaciju

Lucijanić, Marko; Pejša, Vlatko; Mitrović, Zdravko; Štoos-Veić, Tajana; Livun, Ana; Jakšić, Ozren; Vasilj, Tamara; Piršić, Mario; Hariš, Višnja; Prka, Željko; Kušec, Rajko
Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome // Hematology (Luxembourg), 21 (2015), 3; 170-174 (međunarodna recenzija, članak, znanstveni)
Lucijanić, M., Pejša, V., Mitrović, Z., Štoos-Veić, T., Livun, A., Jakšić, O., Vasilj, T., Piršić, M., Hariš, V., Prka, Ž. & Kušec, R. (2015) Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome. Hematology (Luxembourg), 21 (3), 170-174.
@article{article, year = {2015}, pages = {170-174}, keywords = {Myelodysplastic syndrome, HFE, C282Y, H63D, Iron metabolism, Overall survival}, journal = {Hematology (Luxembourg)}, volume = {21}, number = {3}, issn = {1024-5332}, title = {Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome}, keyword = {Myelodysplastic syndrome, HFE, C282Y, H63D, Iron metabolism, Overall survival} }
@article{article, year = {2015}, pages = {170-174}, keywords = {Myelodysplastic syndrome, HFE, C282Y, H63D, Iron metabolism, Overall survival}, journal = {Hematology (Luxembourg)}, volume = {21}, number = {3}, issn = {1024-5332}, title = {Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome}, keyword = {Myelodysplastic syndrome, HFE, C282Y, H63D, Iron metabolism, Overall survival} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font